Category: Preprint
Luc Montagnier: 26 Cases of CJD after vaccination
Luc Montagnier, Nobel prize winner and co-discoverer of HIV, warns of an alarming new variant of CJD appearing in some patients after Covid vaccination.… ...More...
Sato Lab: Virological characteristics of XBB.1.5
Japan’s Sato Lab have announced new research into the Omicron XBB.1.5 ‘Kraken’ variant, confirming much about what is already known or suspected about its transmissibility.… ...More...
Recombinant SARS-CoV-1 and SARS-CoV-2 variant found in Chinese bats
A new preprint out today has been looking at viruses in Chinese bats and has turned up some surprises – it looks like a recombinant variant of SARS-CoV-1 and SARS-CoV-2 has been found!… ...More...
Preprint: Two thirds of first-wave Covid cases have long Covid
The proportion of patients with at least 1 post–COVID-19 symptom 2 years after acute infection was 59.7% for hospitalized patients and 67.5% for those not requiring hospitalization.… ...More...
Preprint: Neutralizing antibodies in deer for at least 13 months for 90% of animals
Another preprint out recently outlines the disturbing prospect of a large SARS-CoV-2 viral reservoir developing in white-tailed deer in the US. … ...More...
Lancet: Protection from previous natural infection compared with mRNA vaccination
The Lancet have published a new article comparing the protection given by a previous SARS-CoV-2 infection versus mRNA vaccination.… ...More...
Preprint: Neutralizing antibody escape of BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
A recent preprint looks at the neutralizing antibody escape abilities for several new variants causing concern across the globe.… ...More...
Coinfection with influenza and RSV creates a new type of virus pathogen
An article in Nature Microbiology describes how a coinfection of influenza A and RSV can create never before seen hybrid virus particles.… ...More...
Preprint: SARS-CoV-2 may have originated as an infectious clone assembled in vitro
A new preprint out today finds that SARS-COV-2 has “a synthetic fingerprint unlikely to have evolved from its close relatives.”… ...More...
Chimeric SARS-CoV-2 variant with a mortality rate of 80% *5 Updates*
Boston University scientists undertake a gain of function experiment and create a chimeric recombinant SARS-CoV-2 virus with 80% mortality rate in mice.… ...More...